Thor Medical ASA (FRA:8NN)

Germany flag Germany · Delayed Price · Currency is EUR
0.4500
+0.0120 (2.74%)
At close: Jan 2, 2026
105.95%
Market Cap155.75M
Revenue (ttm)8.42K
Net Income (ttm)-4.96M
Shares Outn/a
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume230
Average Volume267
Open0.4500
Previous Close0.4380
Day's Range0.4500 - 0.4500
52-Week Range0.1570 - 0.4500
Betan/a
RSI67.18
Earnings DateFeb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2009
Employees 9
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8NN
Full Company Profile

Financial Performance

Financial numbers in NOK Financial Statements

News

There is no news available yet.